Recently, Mellai et al showed that promoter hypermethylation of the EMP3 gene prevailed in low-grade tumors, especially in gliomas with an oligodendroglial component, and in secondary GBMs upon primary GBMs [6]. Here, EMP3 is linked to glioma.